ORIGINAL RESEARCH article

Front. Endocrinol., 22 May 2020

Sec. Thyroid Endocrinology

Volume 11 - 2020 | https://doi.org/10.3389/fendo.2020.00271

Petal-Like Calcifications in Thyroid Nodules on Ultrasonography: A Rare Morphologic Characteristic of Calcification Associated With Aggressive Biological Behavior

  • Department of Ultrasound Diagnosis, Second Xiangya Hospital, Central South University, Changsha, China

Abstract

This study investigated a rare ultrasonographically detected thyroid petal-like calcification and its relationship with thyroid carcinoma and biological behavior. We described the clinical and ultrasonographical features of thyroid nodules with petal-like calcifications in 18 patients undergoing thyroid surgery and cervical lymph node dissection. All of the thyroid nodules with petal-like calcifications were papillary thyroid carcinomas (PTCs). Of the 18 patients, 13 (72.2%) had cervical central lymph node metastasis, and five (27.8%) had cervical lateral lymph node metastasis. Petal-like calcifications occurred in malignant thyroid nodules with a high incidence of lymph node metastasis, which may be a specific ultrasonographic feature associated with the aggressive biological behavior of PTC.

Introduction

Calcifications are commonly detected by ultrasonographic images in thyroid nodules and could be classified into various patterns (1–6). Taki et al. classified calcifications into microcalcifications, intranodular coarse calcifications, peripheral calcifications, and calcified spots (7). Kim et al. further classified peripheral calcifications into annular-like peripheral calcifications and crescent-like peripheral calcifications (2, 3). Among these subtypes, microcalcifications are known to be highly associated with papillary thyroid carcinoma (PTC) (4, 5). Kobayashi et al. reported that, out of 941 PTC patients, 32.0% patients had microcalcifications, and, out of 407 thyroid nodules with microcalcification, 301 (74.0%) were PTC (4). Yin et al. reported that, among 339 thyroid nodules with microcalcification, 210 (61.9%) of them were PTC, and, of 312 PTC patients, 210 (63.1%) had microcalcifications (5). However, to our knowledge, there are no studies on the ultrasonographic features of petal-like calcifications in thyroid nodules. In this study, we investigated the detection of petal-like calcifications by ultrasound and their relationship with thyroid carcinoma and biological behavior.

Methods

Patients

A total of 18 patients with 18 nodules with petal-like calcifications that were detected with preoperative conventional ultrasound (US) and contrasted-enhanced ultrasound (CEUS) and underwent postoperative histopathologic analysis following resected hemithyroidectomy or total thyroidectomy from December 2016 to November 2019 were enrolled in this prospective study. Of the 18 patients, five underwent cervical central and lateral lymph node dissection, and 13 only underwent central lymph node dissection.

Ultrasound Examination

The thyroid nodules were imaged with a Siemens Acuson S3000 US scanner equipped with a 9L4 linear array transducer (Siemens Medical Solutions, Mountain View, CA, USA; transducer frequency: 4–9 MHz) and/or an 18L6 linear array transducer (6–18 MHz). Petal-like calcifications appeared as scattered hyperechogenic spots <2 mm in diameter around solid thyroid nodules with the appearance of flower petals and had a cystic-like dark area ahead of each hyperechogenic spot. The cystic dark area and hyperechogenic spot constituted black-and-white foci (Figure 1). The thyroid nodules with petal-like calcifications often showed acoustic posterior reinforcement. In addition to age, sex, and serum thyroid hormone, which included thyroid-stimulating hormone (TSH), free thyroxine, free triiodothyronine, thyroid peroxidases antibody (A-TPO), and thyroglobulin antibody (A-TG), the US features of the thyroid nodules were recorded, including tumor size, composition, shape, margin, echogenicity, posterior reinforcement, vascularity, and capsule contact with protrusion (8, 9). The US performance of the thyroid nodules was classified according to the Thyroid Imaging Reporting and Data System (TI-RADS) diagnostic classification by Kwak et al. (10).

Figure 1

CEUS was performed using contrast pulsed sequencing technology with a low mechanical index following intravenous injection of SonoVue microbubbles (Bracco, Italy). CEUS videos were recorded for at least 60 s with dedicated software (Contrast Dynamics, Mountain View, CA, USA). With respect to the surrounding thyroid parenchyma enhancement, the time-intensity curves (TICs) of the thyroid nodules with regions of interest (ROIs) were acquired, and CEUS features were classified (8, 9), including enhancement type, peak intensity (PI), time to peak (TP), and area under the curve (AUC). The PI, TP, and AUC of the nodules are reported as indices by the ratio of the region of interest in the nodules to the region of interest in the thyroid parenchymal tissue.

Histopathological Diagnosis

The histopathological results obtained after surgery were used as the only reference standard for the final diagnoses of the thyroid nodules. Patients were staged according to the eighth edition of the American Joint Committee on Cancer (AJCC)/Tumor Lymph Node Metastasis (TNM) staging system (11–13).

Results

In this study, a total of 18 patients with 18 nodules with petal-like calcifications were summarized for their clinical, ultrasonographic and pathologic characteristics. The clinical characteristics of the 18 patients with petal-like calcifications were summarized in Table 1. After surgery, all the patients with petal-like calcifications were histopathologically confirmed as the histological classic variant PTC. A total of 18 PTC patients (four men and 14 women, age mean: 30.17 ± 7.29 y, range: 18–40 y) with petal-like calcifications were included in the analysis. Of the 18 patients, nine (50.0%) had Hashimoto thyroiditis, six (33.3%) had multiple nodules, six (33.3%) had A-TPO increased, and five (27.8%) had A-TG increased.

Table 1

Characteristicsn%
SEX
Male422.2
Female1477.8
Age (years)30.17 ± 7.29 (18–40)
≤ 55 y18100
> 55 y00
MULTIFOCALITY
Yes633.3
No1266.7
HASHIMOTO THYROIDITIS
Yes950.0
No950.0
TSH
Normal18100.0
Abnormal00
FREE THYROXINE
Normal18100.0
Abnormal00
FREE TRIIODOTHYRONINE
Normal18100.0
Abnormal00
A-TPO
Increased633.3
Normal1266.7
A-TG
Increased527.8
Normal1372.2

Clinical characteristics.

TSH, thyroid-stimulating hormone; A-TPO, thyroid peroxidases antibody; A-TG, thyroglobulin antibody.

The ultrasonographic characteristics of the thyroid nodules with petal-like calcifications are outlined in Table 2. Among the 18 thyroid nodules in the 18 PTC patients, all nodules were solid in composition; only one (5.6%) had taller than wider shapes, 11 (61.1%) had ill-defined margins (Figures 2–4), 17 (94.4%) had marked hypoechoic or hypoechoic echogenicity (Figures 2–4), seven (38.9%) had acoustic posterior reinforcement (Figures 2, 3), 12 (66.7%) had capsule contact with protrusion (Figure 4), and six (33.3%) had internal vascularity (Figures 2, 4). From CEUS examination, 11 (61.1%) nodules had a hyper- or isoenhancement type (Figures 3, 4), which meant the majority of the nodules underwent a higher or equal enhancement compared with those of parenchymal tissue. Fifteen (83.3%) had a centripetal perfusion pattern (Figures 3, 4), representing most of the nodules received the perfusion of microbubbles from the periphery to the center. Twelve (66.7%) had a PI index ≥1 (Figures 3, 4), indicating that 66.7% of nodules had a higher PI than those of parenchymal tissue. Eight (44.4 %) had a TP index ≥1 (Figure 4), implying that 44.4% of nodules had a longer or equal time to peak as the parenchymal tissue. And 10 (55.6%) had an AUC index ≥1 (Figures 3, 4), showing that 55.6% of nodules had a higher AUC than those of parenchymal tissue. According to the Kwak TI-RADS classification, 18 nodules (100%) were classified as category 4c (three or four suspicious US features; high possibility of malignancy).

Table 2

Characteristicsn%
Conventional US parameters
TALLER THAN WIDE SHAPE
Yes15.6
No1794.4
ILL-DEFINED MARGIN
Yes1161.1
No738.9
HYPOECHOIC ECHOGENICITY
Yes1794.4
No15.6
POSTERIOR TRANSLUCENCY
Yes738.9
No1161.1
CAPSULE CONTACT WITH PROTRUSION
Yes1266.7
No633.3
INTERNAL VASCULARITY
Yes633.3
No1266.7
CEUS parameters
HYPER-OR ISO ENHANCEMENT TYPE
Yes1161.1
No738.9
CENTRIPETAL PERFUSION PATTERN
Yes1583.3
No316.7
PI INDEX≥1
Yes1266.7
No633.3
TP INDEX≥1
Yes844.4
No1055.6
AUC Index≥1
Yes1055.6
No844.4

Ultrasonographic characteristics.

US, ultrasound; CEUS, contrast-enhanced ultrasound; PI, peak intensity; TP, time to peak; AUC, area under the curve.

Figure 2

Figure 3

Figure 4

The pathologic characteristics of all the patients are summarized in Table 3. Of the 18 patients, five underwent cervical central and lateral lymph node dissection, and 13 underwent central lymph node dissection. According to the eighth edition of the AJCC/TNM staging system, all patients were in TNM stage I and had no obvious distant metastases (M0 classification). The mean diameter of PTCs with petal-like calcifications was 16.72 ± 9.01 mm (range: 6–34 mm), and 13 (72.2%) patients had a tumor size > 10 mm (T1 classification). After histopathological diagnosis, five (27.8%) patients were shown to have both cervical central and lateral lymph node metastasis (N1b classification), eight (44.4%) were shown to have cervical central lymph node metastasis (N1a classification), and the last five (27.8%) had no cervical lymph node metastasis (N0 classification).

Table 3

Characteristicsn%
Tumor size (mm)16.72 ± 9.01 (6–34)
≤ 10 mm527.8
> 10 mm1372.2
T CLASSIFICATION
T11372.2
T2527.8
N CLASSIFICATION
N0527.8
N1a844.4
N1b527.8
M CLASSIFICATION
M018100
TNM stage
I18100

Pathological characteristics according to eighth edition of AJCC/TNM classification system.

Discussion

High-resolution US is recommended for preoperative screening of malignant thyroid nodules from benign nodules and evaluating cervical lymph node metastasis (14–16). Previous studies have reported that PTC with cervical lymph node metastasis exhibits aggressive behavior and is associated with a poor prognosis (13, 14). As one of the more suspicious thyroid sonographic features, microcalcification has been proven to be highly predictive of central compartment lymph node metastases (17, 18). However, to our knowledge, it is rare for ultrasound to detect thyroid nodule petal-like calcifications, and their relationship with thyroid carcinoma has never been reported before.

In the present study, we collected 18 thyroid nodules with petal-like calcifications, which appeared as many scattered hyperechogenic spots around solid thyroid nodules with the appearance of flower petals, with a cystic-like dark area ahead of each hyperechogenic spot. The histopathologic result from all the patients was PTC, and 13 (72.2%) patients had cervical lymph node metastasis; however, previous studies have indicated that only 60–75% of thyroid nodules with microcalcification were PTC (4, 5), which indicates that petal-like calcifications in thyroid nodules are a fairly special sonographic characteristic of PTC and are highly associated with cervical lymph node metastasis. Fortunately, owing to the young mean age of our sample population, all patients in this study were in TNM stage I according to the eighth edition of the AJCC/TNM staging system.

According to the Kwak TI-RADS classification, five US suspicious features (solid composition, marked hypo-echogenicity or hyper-echogenicity, irregular or microlobulated margins, taller-than-wide shape, and presence of microcalcifications) were used to categorize the thyroid nodules, with TI-RADS scores of 3 (no suspicious US features), 4a (one suspicious US feature), 4b (two suspicious US features), 4c (three or four suspicious US features), and 5 (five suspicious US features) (10). In the current study, all thyroid nodules with petal-like calcifications presented with a solid composition and microcalcifications, two suspicious US features according to the Kwak TI-RADS classification guidelines from 2011 (10). In addition, the majority of these nodules had ill-defined margins and marked hypoechoic or hypoechoic echogenicity. The nodules consequently had a high TI-RADS classification due to the presence of three or four suspicious US features. Furthermore, CEUS characteristics showed that the majority of nodules had a hyper- or isoenhancement type, a centripetal perfusion pattern, a PI index ≥1 and an AUC index ≥1. Huang et al. reported that hyper- or iso-enhancement was one of the most useful US features for predicting the presence of cervical central lymph node metastasis (18), which is consistent with our results, demonstrating that the plentiful blood supply of the thyroid tumor may be associated with the aggressive biological behavior of PTC.

This study had many limitations. Firstly, all of the nodules with petal-like calcifications identified in our study ended up being PTC. So, data on whether benign thyroid nodules display such petal-like calcifications is lacking in our study. The sample size of our study population was small. Second, an unavoidable selection bias existed due to only patients who underwent surgery included in this study. A large-scale study is needed in the future to evaluate the association of petal-like calcifications with their corresponding pathogenetic characteristic.

Conclusions

In conclusion, we first reported a special pattern of calcification in thyroid nodules, petal-like calcifications, which only occurred in malignant nodules with a high incidence of lymph node metastasis. This kind of calcification appears as numerous scattered hyperechogenic spots around solid thyroid nodules with the appearance of flower petals, with a cystic-like dark area ahead of each hyperechogenic spot in ultrasonographic images, which is called black-and-white foci. In addition, the majority of these nodules had ill-defined margins, marked hypoechoic or hypoechoic echogenicity, capsule contact with protrusion, a hyper- or isoenhancement type, a centripetal perfusion pattern, a PI index ≥1 and an AUC index ≥1. Therefore, petal-like calcifications in thyroid nodules may be a specific ultrasonographic feature associated with the aggressive biological behavior of PTC.

Statements

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.

Ethics statement

The studies involving human participants were reviewed and approved by the ethics committee of the Second Xiangya Hospital of Central South University. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.

Author contributions

CN contributed to the conception and design of the work. QP and CN participated to data analysis and manuscript writing. QZ and SC participated to data collection and patient follow-up.

Acknowledgments

This project was funded by the National Natural Science Foundation of China (Grant No. 81974267 and 81601883), Hunan Provincial Natural Science Foundation of China (Grant 2018JJ3861 and 2018JJ2575), and Hunan Provincial Health Commission Research Foundation Project (B2019166).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1.

    ParkMShinJHHanBKKoEYHwangHSKangSSet al. Sonography of thyroid nodules with peripheral calcifications. J Clin Ultrasound. (2009) 37:324–8. 10.1002/jcu.20584

  • 2.

    KimBKChoiYSKwonHJLeeJSHeoJJHanYJet al. Relationship between patterns of calcification in thyroid nodules and histopathologic findings. Endocr J. (2013) 60:155–60. 10.1507/endocrj.ej12-0294

  • 3.

    KimBKLeeEMKimJHOakSYKwonSKChoiYSet al. Relationship between ultrasonographic and pathologic calcification patterns in papillary thyroid cancer. Medicine. (2018) 97:e12675. 10.1097/MD.0000000000012675

  • 4.

    KobayashiKFujimotoTOtaHHirokawaMYabutaTMasuokaHet al. Calcifications in thyroid tumors on ultrasonography: calcification types and relationship with histopathological type. Ultrasound Int Open. (2018) 4:E45–51. 10.1055/a-0591-6070

  • 5.

    YinLZhangWBaiWHeW. Relationship between morphologic characteristics of ultrasonic calcification in thyroid nodules and thyroid carcinoma. Ultrasound Med Biol. (2020) 46:20–5. 10.1016/j.ultrasmedbio.2019.09.005

  • 6.

    MalhiHSVelezEKazmierskiBGulatiMDeurdulianCCenSYet al. Peripheral thyroid nodule calcifications on sonography: evaluation of malignant potential. AJR Am J Roentgenol. (2019) 213:672–5. 10.2214/AJR.18.20799

  • 7.

    TakiSTerahataSYamashitaRKinuyaKNobataKKakudaKet al. Thyroid calcifications: sonographic patterns and incidence of cancer. Clin Imaging. (2004) 28:368–71. 10.1016/S0899-7071(03)00190-6

  • 8.

    PengQNiuCZhangMPengQChenS. Sonographic characteristics of papillary thyroid carcinoma with coexistent hashimoto's thyroiditis: conventional ultrasound, acoustic radiation force impulse imaging and contrast-enhanced ultrasound. Ultrasound Med Biol. (2019) 45:471–80. 10.1016/j.ultrasmedbio.2018.10.020

  • 9.

    PengQNiuCZhangQZhangMChenSPengQ. Mummified thyroid nodules: conventional and contrast-enhanced ultrasound features. J Ultrasound Med. (2019) 38:441–52. 10.1002/jum.14712

  • 10.

    KwakJYHanKHYoonJHMoonHJSonEJParkSHet al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. (2011) 260:892–9. 10.1148/radiol.11110206

  • 11.

    CasellaCMinistriniSGalaniAMastrialeFCappelliCPortolaniN. The new TNM staging system for thyroid cancer and the risk of disease downstaging. Front Endocrinol. (2018) 9:541. 10.3389/fendo.2018.00541

  • 12.

    SuhSKimYHGohTSLeeJJeongDCOhSOet al. Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer. Endocrine. (2017) 58:495–502. 10.1007/s12020-017-1449-4

  • 13.

    LamartinaLGraniGArvatENervoAZatelliMCRossiRet al. 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr Relat Cancer. (2018) 25:L7–11. 10.1530/ERC-17-0453

  • 14.

    HaugenBRAlexanderEKBibleKCDohertyGMMandelSJNikiforovYEet al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. (2016) 26:1–133. 10.1089/thy.2015.0020

  • 15.

    TesslerFNMiddletonWDGrantEGHoangJKBerlandLLTeefeySAet al. ACR Thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. (2017) 14:587–95. 10.1016/j.jacr.2017.01.046

  • 16.

    American Thyroid Association Guidelines Taskforce on Thyroid, Differentiated Thyroid CCooperDSDohertyGMHaugenBRKloosRTet al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. (2009) 19:1167–214. 10.1089/thy.2009.0110

  • 17.

    ChenJLiXLZhaoCKWangDWangQLiMXet al. Conventional ultrasound, immunohistochemical factors and BRAF(V600E) mutation in predicting central cervical lymph node metastasis of papillary thyroid carcinoma. Ultrasound Med Biol. (2018) 44:2296–306. 10.1016/j.ultrasmedbio.2018.06.020

  • 18.

    HongYRYanCXMoGQLuoZYZhangYWangYet al. Conventional US. elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases. Sci Rep. (2015) 5:7748. 10.1038/srep07748

Summary

Keywords

petal-like calcifications, conventional ultrasound, contrast-enhanced ultrasound, papillary thyroid carcinoma, lymph node metastasis

Citation

Peng Q, Zhang Q, Chen S and Niu C (2020) Petal-Like Calcifications in Thyroid Nodules on Ultrasonography: A Rare Morphologic Characteristic of Calcification Associated With Aggressive Biological Behavior. Front. Endocrinol. 11:271. doi: 10.3389/fendo.2020.00271

Received

05 February 2020

Accepted

14 April 2020

Published

22 May 2020

Volume

11 - 2020

Edited by

Christoph Reiners, University Hospital Würzburg, Germany

Reviewed by

Roberto Vita, University of Messina, Italy; Sriram Gubbi, National Institutes of Health (NIH), United States

Updates

Copyright

*Correspondence: Chengcheng Niu

This article was submitted to Thyroid Endocrinology, a section of the journal Frontiers in Endocrinology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics